YU44039B - Process for producing 1-oxadethiacephalosporins - Google Patents

Process for producing 1-oxadethiacephalosporins

Info

Publication number
YU44039B
YU44039B YU1738/83A YU173883A YU44039B YU 44039 B YU44039 B YU 44039B YU 1738/83 A YU1738/83 A YU 1738/83A YU 173883 A YU173883 A YU 173883A YU 44039 B YU44039 B YU 44039B
Authority
YU
Yugoslavia
Prior art keywords
oxadethiacephalosporins
producing
Prior art date
Application number
YU1738/83A
Other languages
English (en)
Other versions
YU173883A (en
Inventor
M Narisada
W Nagata
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3340176A external-priority patent/JPS52122386A/ja
Priority claimed from JP5029576A external-priority patent/JPS52133997A/ja
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of YU173883A publication Critical patent/YU173883A/xx
Publication of YU44039B publication Critical patent/YU44039B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D505/00—Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
YU1738/83A 1976-03-25 1983-08-23 Process for producing 1-oxadethiacephalosporins YU44039B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP3340176A JPS52122386A (en) 1976-03-25 1976-03-25 Cephalosporin analogous compounds as antibacterials
JP5029576A JPS52133997A (en) 1976-04-30 1976-04-30 Cephalosporin antibiotics

Publications (2)

Publication Number Publication Date
YU173883A YU173883A (en) 1983-12-31
YU44039B true YU44039B (en) 1990-02-28

Family

ID=26372085

Family Applications (2)

Application Number Title Priority Date Filing Date
YU1737/83A YU44038B (en) 1976-03-25 1983-08-23 Process for producing 1-oxadethiacephalosporins
YU1738/83A YU44039B (en) 1976-03-25 1983-08-23 Process for producing 1-oxadethiacephalosporins

Family Applications Before (1)

Application Number Title Priority Date Filing Date
YU1737/83A YU44038B (en) 1976-03-25 1983-08-23 Process for producing 1-oxadethiacephalosporins

Country Status (19)

Country Link
AR (1) AR224606A1 (xx)
BG (1) BG31074A3 (xx)
CY (1) CY1158A (xx)
DD (1) DD129792A5 (xx)
DE (1) DE2713370C2 (xx)
DK (1) DK161331C (xx)
ES (5) ES457174A1 (xx)
GR (1) GR61146B (xx)
HK (1) HK46882A (xx)
HU (1) HU172720B (xx)
IE (1) IE44794B1 (xx)
IL (1) IL51743A (xx)
MX (1) MX4348E (xx)
NO (2) NO158505C (xx)
NZ (1) NZ183687A (xx)
PT (1) PT66346B (xx)
RO (2) RO78228A (xx)
SE (1) SE443143B (xx)
YU (2) YU44038B (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU514377B2 (en) * 1977-02-15 1981-02-05 Shionogi & Co., Ltd. l-OXADETHIACEPHAM COMPOUNDS
US4252953A (en) * 1979-05-01 1981-02-24 Eli Lilly And Company Antibiotic crystalline epimer
JPS60123490A (ja) * 1983-12-07 1985-07-02 Shionogi & Co Ltd マロニルオキサセフェムカルボン酸誘導体

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL178005C (nl) * 1972-11-06 1986-01-02 Merck & Co Inc Werkwijze voor het bereiden van een farmaceutisch preparaat met antibacteriele werking, alsmede werkwijze ter bereiding van een cefalosporine-antibioticum.
US3962232A (en) * 1973-11-05 1976-06-08 Eli Lilly And Company 7-methoxycephalosporins
GB1449420A (en) * 1973-11-26 1976-09-15 Sankyo Co 7alpha-methoxycephalosporing derivatives

Also Published As

Publication number Publication date
BG31074A3 (en) 1981-10-15
ES469284A1 (es) 1978-11-16
ES469286A1 (es) 1979-09-16
HK46882A (en) 1982-11-19
DK131277A (da) 1977-09-26
YU44038B (en) 1990-02-28
ES469285A1 (es) 1979-09-16
IL51743A (en) 1980-10-26
DK161331B (da) 1991-06-24
GR61146B (en) 1978-09-27
NZ183687A (en) 1979-01-11
ES469287A1 (es) 1979-09-16
SE443143B (sv) 1986-02-17
NO158505C (no) 1988-09-21
RO71742A (ro) 1982-02-26
IE44794L (en) 1977-09-25
HU172720B (hu) 1978-11-28
CY1158A (en) 1983-01-28
PT66346B (en) 1978-08-16
NO158505B (no) 1988-06-13
DE2713370C2 (de) 1994-04-21
DD129792A5 (de) 1978-02-08
YU173783A (en) 1983-12-31
ES457174A1 (es) 1978-08-16
AR224606A1 (es) 1981-12-30
NO862107L (no) 1977-09-27
DE2713370A1 (de) 1977-09-29
NO771023L (no) 1977-09-27
RO78228A (ro) 1982-02-01
IE44794B1 (en) 1982-04-07
PT66346A (en) 1977-04-01
MX4348E (es) 1982-04-05
YU173883A (en) 1983-12-31
SE7703325L (sv) 1977-09-26
DK161331C (da) 1991-12-09

Similar Documents

Publication Publication Date Title
HU179344B (en) Process for producing andorstan-17-one derivatives
JPS5329399A (en) Process for producing polyetherrpolyol
HU177073B (en) Process for producing cyrally substituted 2-imidasolin-5-ones
YU98777A (en) Process for producing antibiotical agentes
HU174836B (hu) Sposob poluchenija meta-fenoksi-benzaldegida
JPS538699A (en) Process for producing nonnfoammlike object
HU175096B (hu) Sposob poluchenija proizvodnykh tiazolidina
HU174416B (hu) Sposob poluchenija proizvodnykh izotiazolopiridina
HU179201B (en) Process for producing halogenophenyl-nonatetraene derivatives
JPS5358593A (en) Process for producing low molecularrweight polyyanhydrides
HU177757B (en) Process for producing corticoide derivatives
HU175013B (hu) Sposob poluchenija kompozicii korma
HU172938B (hu) Sposob poluchenija zamehhennykh fenilacetilenov
HU175361B (hu) Sposob poluchenija novykh 1-sul'fonil-5-skobka-6-skobka zakryta-zamehhennykh-benzimidazolov
HU178640B (en) Process for producing thiaprostaglandine derivatives
YU161182A (en) Process for producing azol-amides
JPS5323391A (en) Process for producing sbrrrubber
HU179561B (en) Process for producing neoviridogrisein-antibiotics
HU177745B (en) Process for producing imidasole derivatives
HU178104B (en) Process for producing tiochromane derivatives
HU174676B (hu) Sposob poluchenija proizvodnykh indazola
HU174803B (hu) Sposob poluchenija proizvodnykh 1-karbamoil-uracila
YU173883A (en) Process for producing 1-oxadethiacephalosporins
HU175130B (hu) Sposob poluchenija proizvodnykh kinolona
JPS537794A (en) Process for producing impacttresistant polysyrene